Jump Financial, LLC Ovid Therapeutics Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	BUY	$3.23 - $3.97 $51,069 - $62,769	15,811 New	15,811 $60,000
Q3 2023 Nov 07, 2023	BUY	$3.23 - $3.97 $51,069 - $62,769	15,811 New	15,811 $60,000
Q1 2022 May 12, 2022	SELL	$2.65 - $3.49 $43,990 - $57,934	-16,600 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$3.13 - $3.73 $51,958 - $61,918	16,600 New	16,600 $53,000
Q3 2021 Nov 12, 2021	SELL	$3.31 - $4.04 $53,622 - $65,448	-16,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.3 - $4.49 $53,460 - $72,738	16,200 New	16,200 $63,000
Q4 2020 Feb 12, 2021	SELL	$2.28 - $6.84 $28,043 - $84,132	-12,300 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$5.39 - $8.24 $66,297 - $101,352	12,300 New	12,300 $70,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.